Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease

被引:69
作者
Mehanna, Raja [1 ]
Smilowska, Katarzyna [2 ,3 ]
Fleisher, Jori [4 ]
Post, Bart [5 ]
Hatano, Taku [6 ]
Piemonte, Maria Elisa Pimentel [7 ]
Kumar, Kishore Raj [8 ,9 ,10 ]
McConvey, Victor [11 ]
Zhang, Baorong [12 ]
Tan, Eng-King [13 ]
Savica, Rodolfo [14 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, UTMove, Houston, TX 77030 USA
[2] Silesian Ctr Neurol, Dept Neurol, Katowice, Poland
[3] 5th Reg Hosp, Dept Neurol, Sosnowiec, Poland
[4] Rush Univ, Sch Med, Dept Neurol Sci, Chicago, IL 60612 USA
[5] Radboudumc, Dept Neurol, Nijmegen, Netherlands
[6] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan
[7] Univ Sao Paulo, Phys Therapy Speech Therapy & Occupat Therapy Dep, Med Sch, Sao Paulo, Brazil
[8] Univ Sydney, Fac Med & Hlth, Concord Repatriat Gen Hosp, Mol Med Lab, Sydney, NSW, Australia
[9] Univ Sydney, Fac Med & Hlth, Concord Repatriat Gen Hosp, Dept Neurol, Sydney, NSW, Australia
[10] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia
[11] Parkinsons Victoria, Elwood, Vic, Australia
[12] Second Affiliated Hosp, Dept Neurol, Hangzhou, Peoples R China
[13] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore
[14] Mayo Clin, Dept Neurol, Rochester, MN USA
关键词
Parkinson's disease; early onset; young onset; age cutoff; QUALITY-OF-LIFE; YOUNG-ONSET; REPRODUCTIVE FACTORS; CLINICAL-FEATURES; ESTROGEN USE; FAMILIAL AGGREGATION; GENDER-DIFFERENCES; CAUDATE-NUCLEUS; RISK; WOMEN;
D O I
10.1002/mdc3.13523
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Early-onset Parkinson's disease (EOPD)/young-onset Parkinson's disease (YOPD) is defined as Parkinson's disease (PD) with an age at onset (AAO) after age 21 years but before the usual AAO for PD. Consensus is lacking, and the reported maximal age for EOPD/YOPD has varied from 40 to 60 years, leading to a lack of uniformity in published studies and difficulty in harmonization of data. EOPD and YOPD have both been used in the literature, somewhat interchangeably. Objective To define the nomenclature and AAO cutoff for EOPD/YOPD. Methods An extensive review of the literature and task force meetings were conducted. Conclusions were reached by consensus. Results First, the literature has seen a shift from the use of YOPD toward EOPD. This seems motivated by an attempt to avoid age-related stigmatization of patients. Second, in defining EOPD, 56% of the countries use 50 or 51 years as the cutoff age. Third, the majority of international genetic studies in PD use an age cutoff of younger than 50 years to define EOPD. Fourth, many studies suggest that changes in the estrogen level can affect the predisposition to develop PD, making the average age at menopause of 50 years an important factor to consider when defining EOPD. Fifth, considering the differential impact of the AAO of PD on professional and social life, using 50 years as the upper cutoff for the definition of EOPD seems reasonable. Conclusions This task force recommends the use of EOPD rather than YOPD. It defines EOPD as PD with AAO after 21 years but before 50 years.
引用
收藏
页码:869 / 878
页数:10
相关论文
共 142 条
[21]  
Crosiers David, 2012, Am J Neurodegener Dis, V1, P160
[22]   Postmenopausal estrogen use affects risk for Parkinson disease [J].
Currie, LJ ;
Harrison, MB ;
Trugman, JM ;
Bennett, JP ;
Wooten, GF .
ARCHIVES OF NEUROLOGY, 2004, 61 (06) :886-888
[23]   Difficulties in activities of daily living are associated with stigma in patients with Parkinson's disease who are candidates for deep brain stimulation [J].
da Silva, Antonio G. ;
Leal, Vanessa P. ;
da Silva, Paulo R. ;
Freitas, Fernando C. ;
Linhares, Marcelo N. ;
Walz, Roger ;
Malloy-Diniz, Leandro F. ;
Diaz, Alexandre P. ;
Palha, Antonio P. .
BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (02) :190-194
[24]   Update on models of basal ganglia function and dysfunction [J].
DeLong, Mahlon ;
Wichmann, Thomas .
PARKINSONISM & RELATED DISORDERS, 2009, 15 :S237-S240
[25]   The genetics of Parkinson disease [J].
Deng, Hao ;
Wang, Peng ;
Jankovic, Joseph .
AGEING RESEARCH REVIEWS, 2018, 42 :72-85
[26]   Inhibition of striatal dopamine transporter activity by 17β-estradiol [J].
Disshon, KA ;
Boja, JW ;
Dluzen, DE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (02) :207-211
[27]   Motor subtype changes in early Parkinson's disease [J].
Eisinger, Robert S. ;
Hess, Christopher W. ;
Martinez-Ramirez, Daniel ;
Almeida, Leonardo ;
Foote, Kelly D. ;
Okun, Michael S. ;
Gunduz, Aysegul .
PARKINSONISM & RELATED DISORDERS, 2017, 43 :67-72
[28]   New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression A Prospective Cohort Comparison With Other Phenotypes [J].
Fereshtehnejad, Seyed-Mohammad ;
Romenets, Silvia Rios ;
Anang, Julius B. M. ;
Latreille, Veronique ;
Gagnon, Jean-Francois ;
Postuma, Ronald B. .
JAMA NEUROLOGY, 2015, 72 (08) :863-873
[29]   Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients [J].
Fereshtehnejad, Seyed-Mohammad ;
Hadizadeh, Hasti ;
Farhadi, Farzaneh ;
Shahidi, Gholam Ali ;
Delbari, Ahmad ;
Loekk, Johan .
PARKINSONS DISEASE, 2014, 2014
[30]  
Fiala, 2009, GENETIKA PARKINSONOV, V72, P419